Earlier this year The University of Texas Health Science Center at San Antonio (UT Health San Antonio), in partnership with Altus Biologics, launched infusion services at the Medical Arts & Research Center (MARC). With plans to expand in the future, this new service will allow UT Health San Antonio patients to receive novel biologic medications that have revolutionized the treatment of immune-mediated diseases.
Biologic medications play important roles in the treatment of diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus, vasculitis, IgG4-related disease, Crohn’s disease, ulcerative colitis, multiple sclerosis, autoimmune neuropathies and asthma.
“Many of the novel medications that have revolutionized the treatment of autoimmune diseases in the past 20 years are biologic drugs that must be administered by intravenous infusion,” said Agustin Escalante, MD, professor and chief of rheumatology in the Division of Rheumatology and Clinical Immunology. “The new MARC Infusion Services will allow our patients to receive these treatments in the comfort and care of their trusted UT Health Physicians’ providers, clinicians and staff.”
Serving Bexar County, as well as communities throughout Central and South Texas, MARC Infusion Services will administer medications ordered by their physicians. To support UT Health San Antonio’s mission and commitment to educating the next generation of health care professionals, medical residents and fellows also will be able to order infusion medications for patients under their care, under the supervision of board-certified physicians.
“I am pleased that MARC Infusion Services will allow us to provide this long-needed service to our patients without them having to leave the care of their trusted UT Health Physicians,” Dr. Escalante said.
Learn more about the Division of Rheumatology and Clinical Immunology at UT Health San Antonio.